共 80 条
[1]
Andoh T(1987)Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I Proc Natl Acad Sci USA 84 5565-5569
[2]
Ishii K(1997)Elective surgery for gastrointestinal tumors in the elderly Ann Oncol 8 317-326
[3]
Suzuki Y(2000)Geriatric oncology: challenges for the new century Eur J Cancer 36 1741-1754
[4]
Audisio RA(1987)A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis 40 373-383
[5]
Veronesi P(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-345
[6]
Ferrario L(2010)Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer Br J Cancer 103 1524-1528
[7]
Balducci L(2005)Advances in the treatment of metastatic colorectal cancer Oncologist 10 40-48
[8]
Charlson ME(2004)A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23-30
[9]
Pompei P(2004)Survival of patients with advanced colorectal cancer improves with the availability of fluorouracilleucovorin, irinotecan, and oxaliplatin in the course of treatment J Clin Oncol 22 1209-1214
[10]
Ales K(2012)Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer Br J Cancer 106 274-278